Oro Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 17-11-2024
- Paid Up Capital ₹ 6.00 M
as on 17-11-2024
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.03 Cr
as on 17-11-2024
- Revenue -15.25%
(FY 2023)
- Profit 15.23%
(FY 2023)
- Ebitda -10.19%
(FY 2023)
- Net Worth 22.45%
(FY 2023)
- Total Assets 33.85%
(FY 2023)
About Oro Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 6.00 M.
The company currently has active open charges totaling ₹1.03 Cr.
Akshaya Jena, Saswat Jena, and Namita Jena serve as directors at the Company.
- CIN/LLPIN
U24232OR2004PTC007517
- Company No.
007517
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Mar 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Cuttack, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Oro Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akshaya Jena  | Director | 04-Apr-2024 | Current |
| Saswat Jena | Director | 04-Apr-2024 | Current |
| Namita Jena | Director | 04-Apr-2024 | Current |
Financial Performance of Oro Pharmaceuticals.
Oro Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.25% decrease. The company also saw a substantial improvement in profitability, with a 15.23% increase in profit. The company's net worth Soared by an impressive increase of 22.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oro Pharmaceuticals?
In 2023, Oro Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 25 Feb 2022 | ₹2.34 M | Open |
Bank Of India Creation Date: 27 Feb 2006 | ₹8.00 M | Open |
How Many Employees Work at Oro Pharmaceuticals?
Unlock and access historical data on people associated with Oro Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oro Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
